Status:
UNKNOWN
Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Tremor
Involuntary Movements
Eligibility:
All Genders
Brief Summary
Hyperkinetic movement disorders in patients with diseases of motor neurons will be studied. Patients with spinal muscular atrophy (SMA) and motor neuron disease patients will be studied. Involuntary ...
Detailed Description
Background: Minipolymyoclonus and tremor are frequently mentioned as part of the clinical picture of spinal muscular atrophy, but the precise mechanism of the occurrence of tremor and minipolymyoclonu...
Eligibility Criteria
Inclusion
- Genetically proven SMA patients treated with Nusinersen
- ''clinically definite ALS'' or ''clinically probable ALS'' or ''clinically probable ALS - laboratory supported'' according to the revised El Escorial diagnostic criteria or diagnosis of PMA or PLS
Exclusion
- No.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04825119
Start Date
October 1 2017
End Date
July 30 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000